Investigations Required in Postmenopausal Hirsutism
Postmenopausal women with hirsutism require comprehensive hormonal evaluation to rule out serious underlying causes, particularly androgen-secreting tumors of the ovaries or adrenal glands.
Initial Evaluation
- Detailed history focusing on onset and progression of hirsutism, associated symptoms (virilization, menstrual history, infertility), and medication use 1
- Physical examination to assess distribution and severity of hirsutism, signs of virilization (clitoromegaly, deepening voice), truncal obesity, and androgenic alopecia 1, 2
- Evaluation of metabolic parameters due to association with insulin resistance, hypercholesterolemia, and hypertension 2
Essential Laboratory Investigations
Hormonal Panel
- Serum total and free testosterone (preferably by tandem mass spectrometry) - elevated levels >5 nmol/L strongly suggest androgen-producing tumors 3
- Sex hormone-binding globulin (SHBG) - helps calculate free androgen index 1, 2
- Dehydroepiandrosterone sulfate (DHEA-S) - primarily reflects adrenal androgen production 1, 2
- Androstenedione - can be elevated in both ovarian and adrenal disorders 1, 2
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) - to confirm postmenopausal status 1
- Inhibin B - may be elevated in certain ovarian tumors 2
Additional Endocrine Testing
- Morning cortisol and ACTH - to evaluate adrenal function 1
- Tests to exclude Cushing syndrome (overnight dexamethasone suppression test or 24-hour urinary free cortisol) 2
- Thyroid function tests (TSH, free T4) - thyroid dysfunction can affect hormone metabolism 1
- Prolactin - may be elevated in pituitary disorders 1
Imaging Studies
- Transvaginal ultrasound - first-line imaging for ovarian assessment; may identify ovarian enlargement, masses, or polycystic changes 1, 4
- Magnetic resonance imaging (MRI) of the ovaries - when ultrasound is inconclusive or to better characterize ovarian lesions 2, 4
- Computed tomography (CT) or MRI of the adrenal glands - to evaluate for adrenal masses 2, 3
- Pituitary MRI - if central causes are suspected (e.g., elevated prolactin) 1
Special Considerations
- Ovarian hyperthecosis may elude standard imaging studies despite causing significant hyperandrogenism in postmenopausal women 5
- Benign ovarian tumors like cystadenofibroma can cause hyperandrogenism and should be considered even when initial imaging is unremarkable 4
- Rare conditions like hilus cell tumors and stromal luteomas may require surgical exploration for definitive diagnosis 6
Common Pitfalls to Avoid
- Failing to investigate new-onset hirsutism in postmenopausal women - this is never normal and requires thorough evaluation 2, 5
- Overlooking subtle ovarian abnormalities on imaging - repeat imaging or different modalities may be necessary 4, 5
- Attributing symptoms to polycystic ovary syndrome without excluding more serious causes 3
- Neglecting to consider adrenal sources of androgen excess 2, 3
Management Approach
- Referral to endocrinology and gynecology is warranted for all cases of postmenopausal hirsutism 1
- Surgical intervention (bilateral oophorectomy or adrenal tumor removal) is often necessary for definitive diagnosis and treatment of androgen-secreting tumors 3, 6
- Medical management with antiandrogens or GnRH analogs may be considered for women unfit for surgery or when the source of hyperandrogenism remains unidentified 2
Remember that postmenopausal hirsutism, especially when of recent onset, requires prompt and thorough investigation as it may signal serious underlying pathology including malignancy 2, 3, 4.